Reducing alcohol-related harm for Native Hawaiian and Pacific Islander young adults
Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults
This project will try a culturally based program to help Native Hawaiian and Pacific Islander young adults (ages 18–30) lower risky drinking and alcohol-related harms.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-11172262 on NIH RePORTER |
What this research studies
You would be offered a culturally grounded program called SPEAR that was developed with input from Native Hawaiian and Pacific Islander community members and an advisory council. The team will assemble a treatment manual from intervention components shaped in prior work and refine it using citizens' panels that mirror community decision-making. After manual development, SPEAR will be tested with NPI young adults to see if it reduces heavy drinking and alcohol-related problems. The approach combines community-driven design with a controlled efficacy test led by researchers at the University of California Riverside.
Who could benefit from this research
Good fit: Ideal participants are Native Hawaiian or Pacific Islander young adults about 18–30 years old who drink alcohol or are at risk for alcohol use disorders.
Not a fit: People who are not Native Hawaiian or Pacific Islander, who are older than the target age range, or who do not engage in risky drinking are unlikely to gain direct benefit from this intervention.
Why it matters
Potential benefit: If successful, this could reduce risky drinking and lower health, social, and work harms from alcohol among Native Hawaiian and Pacific Islander young adults.
How similar studies have performed: A prior NIAAA R21 shaped the SPEAR components and documented high AUD risk in NPI young adults, but full-scale efficacy testing of this culturally grounded intervention is still novel.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Subica, Andrew Makoto — University of California Riverside
- Study coordinator: Subica, Andrew Makoto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.